Bank of New York Mellon Corp - DICE THERAPEUTICS INC ownership

DICE THERAPEUTICS INC's ticker is and the CUSIP is 23345J104. A total of 70 filers reported holding DICE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of DICE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$5,990,413
+59.1%
128,937
-1.9%
0.00%0.0%
Q1 2023$3,764,152
-11.9%
131,384
-4.1%
0.00%0.0%
Q4 2022$4,273,838
+122.2%
136,982
+44.4%
0.00%
Q3 2022$1,923,000
+73.6%
94,864
+32.8%
0.00%
Q2 2022$1,108,000
+50.3%
71,411
+85.3%
0.00%
Q1 2022$737,000
-12.7%
38,535
+15.6%
0.00%
Q4 2021$844,00033,3430.00%
Other shareholders
DICE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Northpond Ventures, LLC 3,292,871$83,343,00029.17%
Sands Capital Ventures, LLC 3,148,970$79,700,00011.81%
OUP Management Co., LLC 536,693$13,584,0006.12%
New Leaf Venture Partners, L.L.C. 556,693$14,090,0005.10%
Logos Global Management LP 1,664,251$42,122,0004.34%
Asymmetry Capital Management, L.P. 185,201$4,687,0002.49%
Deep Track Capital, LP 1,341,004$33,941,0002.40%
RA Capital Management 5,208,911$131,838,0002.32%
Soleus Capital Management, L.P. 810,940$20,525,0002.06%
Miller Investment Management, LP 180,901$4,579,0000.66%
View complete list of DICE THERAPEUTICS INC shareholders